# Anika Therapeutics, Inc.: Form 8-K, filed Apr 10, 2025

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: 8-K
- Filed: 2025-04-10
- Accepted by EDGAR: Apr 10, 2025, 16:06 ET
- Period: 2025-04-04
- Accession: 0001171843-25-002148
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000117184325002148/f8k_041025.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000117184325002148/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000117184325002148/f8k_041025.htm

Filed Apr 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-002148. Last ingested by Listed: Nov 6, 2026, 15:05 ET. No prices; not investment advice.